Further studies are needed to generate mechanistic insights into the signaling pathways that converge on NF-κB in ccRCC-infiltrating CD8+ T cells and to test whether NF-κB-hijacking of a pro-apoptotic pathway is an immune feature of other cancers (Fig. 5f). This evidence concerns the gene NFKB1 and nonpapillary renal cell carcinoma.